Harvard Bioscience Schedules Third Quarter 2025 Earnings Conference Call for November 6, 2025 at 8:00 AM ET
Rhea-AI Summary
Harvard Bioscience (NASDAQ: HBIO) will report financial results for the quarter ended September 30, 2025 before market open on November 6, 2025. The company will host a conference call to discuss results at 8:00 AM Eastern Time on the same day.
Participants who wish to ask questions must register to receive dial-in numbers and a unique PIN. An audio-only webcast will be available via the company’s Investor Relations events and presentations page. The earnings release and related slide presentation will be posted in the Investor Relations section.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, HBIO gained 41.10%, reflecting a significant positive market reaction. Argus tracked a peak move of +90.3% during that session. Our momentum scanner triggered 66 alerts that day, indicating high trading interest and price volatility. This price movement added approximately $12M to the company's valuation, bringing the market cap to $42M at that time. Trading volume was exceptionally heavy at 379.4x the daily average, suggesting very strong buying interest.
Data tracked by StockTitan Argus on the day of publication.
HOLLISTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended September 30, 2025, before the market opens on November 6, 2025, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.
Participants who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.
Participants who would like to join the audio-only webcast should go to our events and presentations on the investor website here.
Financial information presented on the call, including the earnings release and a related slide presentation, will be available on the Investor Relations section of Harvard Bioscience’s website.
About Harvard Bioscience
Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in the United States, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.
For more information, please visit our website at www.harvardbioscience.com.
Company Contact:
Mark Frost
Interim Chief Financial Officer
(508) 893-3120
investors@harvardbioscience.com
FAQ
When will Harvard Bioscience (HBIO) report Q3 2025 results?
What time is the Harvard Bioscience (HBIO) Q3 2025 earnings call on November 6, 2025?
How can investors register to ask a question on the Harvard Bioscience (HBIO) earnings call?
Where can I listen to the Harvard Bioscience (HBIO) audio-only webcast for the November 6, 2025 call?
When and where will Harvard Bioscience (HBIO) post the Q3 2025 earnings release and slides?
Do I need a PIN to access the Harvard Bioscience (HBIO) conference call on November 6, 2025?
